{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:53:01Z","timestamp":1790751181710,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"24","license":[{"start":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T00:00:00Z","timestamp":1435536000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T00:00:00Z","timestamp":1435536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31172083"],"award-info":[{"award-number":["31172083"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH","award":["CA115414"],"award-info":[{"award-number":["CA115414"]}]},{"name":"Natural Science Foundation of Jiangsu Higher Education Institutions of China","award":["10KJA180027"],"award-info":[{"award-number":["10KJA180027"]}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-08-135-01-CNE"],"award-info":[{"award-number":["RSG-08-135-01-CNE"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovative Research Program of Jiangsu College Graduate of China","award":["KYLX_0714"],"award-info":[{"award-number":["KYLX_0714"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s00018-015-1976-1","type":"journal-article","created":{"date-parts":[[2015,6,28]],"date-time":"2015-06-28T13:25:22Z","timestamp":1435497922000},"page":"4867-4884","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Rapamycin inhibits BAFF-stimulated cell proliferation and survival by suppressing mTOR-mediated PP2A-Erk1\/2 signaling pathway in normal and neoplastic B-lymphoid cells"],"prefix":"10.1007","volume":"72","author":[{"given":"Qingyu","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shile","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,29]]},"reference":[{"key":"1976_CR1","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1084\/jem.189.11.1747","volume":"189","author":"P Schneider","year":"1999","unstructured":"Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N et al (1999) BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189:1747\u20131756","journal-title":"J Exp Med"},{"key":"1976_CR2","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1002\/eji.200838618","volume":"38","author":"T Henley","year":"2008","unstructured":"Henley T, Kovesdi D, Turner M (2008) B-cell responses to B-cell activation factor of the TNF family (BAFF) are impaired in the absence of PI3K delta. Eur J Immunol 38:3543\u20133548","journal-title":"Eur J Immunol"},{"key":"1976_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1126\/science.285.5425.260","volume":"285","author":"PA Moore","year":"1999","unstructured":"Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P et al (1999) BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285:260\u2013263","journal-title":"Science"},{"key":"1976_CR4","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1189\/jlb.0706481","volume":"82","author":"CG Mueller","year":"2007","unstructured":"Mueller CG, Boix C, Kwan WH, Daussy C, Fournier E, Fridman WH et al (2007) Critical role of monocytes to support normal B cell and diffuse large B cell lymphoma survival and proliferation. J Leukoc Biol 82:567\u2013575","journal-title":"J Leukoc Biol"},{"key":"1976_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.coi.2007.04.008","volume":"19","author":"F Mackay","year":"2007","unstructured":"Mackay F, Silveira PA, Brink R (2007) B cells and the BAFF\/APRIL axis: fast-forward on autoimmunity and signaling. Curr Opin Immunol 19:327\u2013336","journal-title":"Curr Opin Immunol"},{"key":"1976_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0165-2478(03)00050-6","volume":"88","author":"P Schneider","year":"2003","unstructured":"Schneider P, Tschopp J (2003) BAFF and the regulation of B cell survival. Immunol Lett 88:57\u201362","journal-title":"Immunol Lett"},{"key":"1976_CR7","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1182\/blood-2008-10-183467","volume":"113","author":"L Fu","year":"2009","unstructured":"Fu L, Lin-Lee YC, Pham LV, Tamayo AT, Yoshimura LC, Ford RJ (2009) BAFF-R promotes cell proliferation and survival through interaction with IKKbeta and NF-\u03baB\/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells. Blood 113:4627\u20134636","journal-title":"Blood"},{"key":"1976_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1365-2249.2009.04007.x","volume":"158","author":"I Moisini","year":"2009","unstructured":"Moisini I, Davidson A (2009) BAFF: a local and systemic target in autoimmune diseases. Clin Exp Immunol 158:155\u2013163","journal-title":"Clin Exp Immunol"},{"key":"1976_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1359-6101(03)00023-6","volume":"14","author":"F Mackay","year":"2003","unstructured":"Mackay F, Ambrose C (2003) The TNF family members BAFF and APRIL: the growing complexity. Cytokine Growth Factor Rev 14:311\u2013324","journal-title":"Cytokine Growth Factor Rev"},{"key":"1976_CR10","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/intimm\/dxh259","volume":"17","author":"X Zhang","year":"2005","unstructured":"Zhang X, Park CS, Yoon SO, Li L, Hsu YM, Ambrose C et al (2005) BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors. Int Immunol 17:779\u2013788","journal-title":"Int Immunol"},{"key":"1976_CR11","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1084\/jem.20060990","volume":"203","author":"A Patke","year":"2006","unstructured":"Patke A, Mecklenbrauker I, Erdjument-Bromage H, Tempst P, Tarakhovsky A (2006) BAFF controls B cell metabolic fitness through a PKC beta- and Akt-dependent mechanism. J Exp Med 203:2551\u20132562","journal-title":"J Exp Med"},{"key":"1976_CR12","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nrrheum.2010.68","volume":"6","author":"I Sanz","year":"2010","unstructured":"Sanz I, Lee FE (2010) B cells as therapeutic targets in SLE. Nat Rev Rheumatol 6:326\u2013337","journal-title":"Nat Rev Rheumatol"},{"key":"1976_CR13","first-page":"1256","volume":"35","author":"S Bosello","year":"2008","unstructured":"Bosello S, Youinou P, Daridon C, Tolusso B, Bendaoud B, Pietrapertosa D et al (2008) Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis. J Rheumatol 35:1256\u20131264","journal-title":"J Rheumatol"},{"key":"1976_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4049\/jimmunol.166.1.6","volume":"166","author":"J Zhang","year":"2001","unstructured":"Zhang J, Roschke V, Baker KP, Wang Z, Alarcon GS, Fessler BJ et al (2001) Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol 166:6\u201310","journal-title":"J Immunol"},{"key":"1976_CR15","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.immuni.2006.04.005","volume":"24","author":"Y Sasaki","year":"2006","unstructured":"Sasaki Y, Derudder E, Hobeika E, Pelanda R, Reth M, Rajewsky K et al (2006) Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 24:729\u2013739","journal-title":"Immunity"},{"key":"1976_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jaut.2012.05.014","volume":"39","author":"D Cornec","year":"2012","unstructured":"Cornec D, Devauchelle-Pensec V, Tobon GJ, Pers JO, Jousse-Joulin S, Saraux A (2012) B cells in Sjogren\u2019s syndrome: from pathophysiology to diagnosis and treatment. J Autoimmun 39:161\u2013167","journal-title":"J Autoimmun"},{"key":"1976_CR17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1600-065X.2008.00625.x","volume":"223","author":"M Ramanujam","year":"2008","unstructured":"Ramanujam M, Davidson A (2008) BAFF blockade for systemic lupus erythematosus: will the promise be fulfilled? Immunol Rev 223:156\u2013174","journal-title":"Immunol Rev"},{"key":"1976_CR18","doi-asserted-by":"publisher","first-page":"12435","DOI":"10.1073\/pnas.0805460105","volume":"105","author":"KL Otipoby","year":"2008","unstructured":"Otipoby KL, Sasaki Y, Schmidt-Supprian M, Patke A, Gareus R, Pasparakis M et al (2008) BAFF activates Akt and Erk through BAFF-R in an IKK1-dependent manner in primary mouse B cells. Proc Natl Acad Sci USA 105:12435\u201312438","journal-title":"Proc Natl Acad Sci USA"},{"key":"1976_CR19","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1182\/blood-2007-03-077222","volume":"111","author":"RT Woodland","year":"2008","unstructured":"Woodland RT, Fox CJ, Schmidt MR, Hammerman PS, Opferman JT, Korsmeyer SJ et al (2008) Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival. Blood 111:750\u2013760","journal-title":"Blood"},{"key":"1976_CR20","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1002\/art.22085","volume":"54","author":"D Fernandez","year":"2006","unstructured":"Fernandez D, Bonilla E, Mirza N, Niland B, Perl A (2006) Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. Arthritis Rheum 54:2983\u20132988","journal-title":"Arthritis Rheum"},{"key":"1976_CR21","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149:274\u2013293","journal-title":"Cell"},{"key":"1976_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrm3757","volume":"15","author":"M Shimobayashi","year":"2014","unstructured":"Shimobayashi M, Hall MN (2014) Making new contacts: the mTOR network in metabolism and signalling crosstalk. Nat Rev Mol Cell Biol 15:155\u2013162","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1976_CR23","first-page":"173","volume":"9","author":"D Fernandez","year":"2010","unstructured":"Fernandez D, Perl A (2010) mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus? Discov Med 9:173\u2013178","journal-title":"Discov Med"},{"key":"1976_CR24","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.cyto.2013.03.011","volume":"62","author":"Z Ke","year":"2013","unstructured":"Ke Z, Liang D, Zeng Q, Ren Q, Ma H, Gui L et al (2013) hsBAFF promotes proliferation and survival in cultured B lymphocytes via calcium signaling activation of mTOR pathway. Cytokine 62:310\u2013321","journal-title":"Cytokine"},{"key":"1976_CR25","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1096\/fj.06-7859rev","volume":"22","author":"MR Junttila","year":"2008","unstructured":"Junttila MR, Li SP, Westermarck J (2008) Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J 22:954\u2013965","journal-title":"FASEB J"},{"key":"1976_CR26","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.cell.2009.10.006","volume":"139","author":"Y Shi","year":"2009","unstructured":"Shi Y (2009) Serine\/threonine phosphatases: mechanism through structure. Cell 139:468\u2013484","journal-title":"Cell"},{"key":"1976_CR27","doi-asserted-by":"publisher","first-page":"21936","DOI":"10.1074\/jbc.M113.467266","volume":"288","author":"K Sunahori","year":"2013","unstructured":"Sunahori K, Nagpal K, Hedrich CM, Mizui M, Fitzgerald LM, Tsokos GC (2013) The catalytic subunit of protein phosphatase 2A (PP2Ac) promotes DNA hypomethylation by suppressing the phosphorylated mitogen-activated protein kinase\/extracellular signal-regulated kinase (ERK) kinase (MEK)\/phosphorylated ERK\/DNMT1 protein pathway in T-cells from controls and systemic lupus erythematosus patients. J Biol Chem 288:21936\u201321944","journal-title":"J Biol Chem"},{"key":"1976_CR28","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1172\/JCI24895","volume":"115","author":"CG Katsiari","year":"2005","unstructured":"Katsiari CG, Kyttaris VC, Juang YT, Tsokos GC (2005) Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus. J Clin Invest 115:3193\u20133204","journal-title":"J Clin Invest"},{"key":"1976_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jneuroim.2011.09.012","volume":"240\u2013241","author":"L Endong","year":"2011","unstructured":"Endong L, Shijie J, Sonobe Y, Di M, Hua L, Kawanokuchi J et al (2011) The gap-junction inhibitor carbenoxolone suppresses the differentiation of Th17 cells through inhibition of IL-23 expression in antigen presenting cells. J Neuroimmunol 240\u2013241:58\u201364","journal-title":"J Neuroimmunol"},{"key":"1976_CR30","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.4049\/jimmunol.1200143","volume":"188","author":"JC Crispin","year":"2012","unstructured":"Crispin JC, Apostolidis SA, Rosetti F, Keszei M, Wang N, Terhorst C et al (2012) Cutting edge: protein phosphatase 2A confers susceptibility to autoimmune disease through an IL-17-dependent mechanism. J Immunol 188:3567\u20133571","journal-title":"J Immunol"},{"key":"1976_CR31","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nrrheum.2013.78","volume":"9","author":"JC Crispin","year":"2013","unstructured":"Crispin JC, Hedrich CM, Tsokos GC (2013) Gene-function studies in systemic lupus erythematosus. Nat Rev Rheumatol 9:476\u2013484","journal-title":"Nat Rev Rheumatol"},{"key":"1976_CR32","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.4049\/jimmunol.174.9.5583","volume":"174","author":"MY Lin","year":"2005","unstructured":"Lin MY, Zal T, Ch\u2019en IL, Gascoigne NR, Hedrick SM (2005) A pivotal role for the multifunctional calcium\/calmodulin-dependent protein kinase II in T cells: from activation to unresponsiveness. J Immunol 174:5583\u20135592","journal-title":"J Immunol"},{"key":"1976_CR33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.33549\/physiolres.931522","volume":"58","author":"JQ Liang","year":"2009","unstructured":"Liang JQ, Zhang W, Wen L, Gao W, Zhang SQ, Chen L (2009) hsBAFF-upregulated intracellular free Ca2+ homeostasis regulates ERK1\/2 activity and cell proliferation in B cells in vitro. Physiol Res 58:411\u2013418","journal-title":"Physiol Res"},{"key":"1976_CR34","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.bcp.2013.11.006","volume":"87","author":"D Liang","year":"2014","unstructured":"Liang D, Zeng Q, Xu Z, Zhang H, Gui L, Xu C et al (2014) BAFF activates Erk1\/2 promoting cell proliferation and survival by Ca2+-CaMKII-dependent inhibition of PP2A in normal and neoplastic B-lymphoid cells. Biochem Pharmacol 87:332\u2013343","journal-title":"Biochem Pharmacol"},{"key":"1976_CR35","doi-asserted-by":"publisher","first-page":"4438","DOI":"10.1073\/pnas.96.8.4438","volume":"96","author":"RT Peterson","year":"1999","unstructured":"Peterson RT, Desai BN, Hardwick JS, Schreiber SL (1999) Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycin associated protein. Proc Natl Acad Sci USA 96:4438\u20134442","journal-title":"Proc Natl Acad Sci USA"},{"key":"1976_CR36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.pep.2005.01.001","volume":"41","author":"P Cao","year":"2005","unstructured":"Cao P, Mei JJ, Diao ZY, Zhang S (2005) Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli. Protein Expr Purif 41:199\u2013206","journal-title":"Protein Expr Purif"},{"key":"1976_CR37","doi-asserted-by":"publisher","first-page":"e10578","DOI":"10.1371\/journal.pone.0010578","volume":"5","author":"L Liu","year":"2010","unstructured":"Liu L, Chen L, Luo Y, Chen W, Zhou H, Xu B et al (2010) Rapamycin inhibits IGF-1 stimulated cell motility through PP2A pathway. PLoS ONE 5:e10578","journal-title":"PLoS ONE"},{"key":"1976_CR38","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.biocel.2008.10.029","volume":"41","author":"L Chen","year":"2009","unstructured":"Chen L, Liu L, Yin J, Luo Y, Huang S (2009) Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway. Int J Biochem Cell Biol 41:1284\u20131295","journal-title":"Int J Biochem Cell Biol"},{"key":"1976_CR39","doi-asserted-by":"publisher","first-page":"38362","DOI":"10.1074\/jbc.M110.141168","volume":"285","author":"L Liu","year":"2010","unstructured":"Liu L, Luo Y, Chen L, Shen T, Xu B, Chen W et al (2010) Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity. J Biol Chem 285:38362\u201338373","journal-title":"J Biol Chem"},{"key":"1976_CR40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1471-4159.2007.05133.x","volume":"105","author":"L Chen","year":"2008","unstructured":"Chen L, Liu L, Luo Y, Huang S (2008) MAPK and mTOR pathways are involved in cadmium-induced neuronal apoptosis. J Neurochem 105:251\u2013261","journal-title":"J Neurochem"},{"key":"1976_CR41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.gde.2004.12.004","volume":"15","author":"V Janssens","year":"2005","unstructured":"Janssens V, Goris J, Van Hoof C (2005) PP2A: the expected tumor suppressor. Curr Opin Genet Dev 15:34\u201341","journal-title":"Curr Opin Genet Dev"},{"key":"1976_CR42","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1042\/bj3530417","volume":"353","author":"V Janssens","year":"2001","unstructured":"Janssens V, Goris J (2001) Protein phosphatase 2A: a highly regulated family of serine\/threonine phosphatases implicated in cell growth and signalling. Biochem J 353:417\u2013439","journal-title":"Biochem J"},{"key":"1976_CR43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc2602","volume":"9","author":"M Malumbres","year":"2009","unstructured":"Malumbres M, Barbacid M (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9:153\u2013166","journal-title":"Nat Rev Cancer"},{"key":"1976_CR44","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1182\/blood-2002-01-0189","volume":"101","author":"T Decker","year":"2003","unstructured":"Decker T, Hipp S, Ringshausen I, Bogner C, Oelsner M, Schneller F et al (2003) Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin. Blood 101:278\u2013285","journal-title":"Blood"},{"key":"1976_CR45","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1097\/01.tp.0000260142.38619.9c","volume":"83","author":"M Vaysberg","year":"2007","unstructured":"Vaysberg M, Balatoni CE, Nepomuceno RR, Krams SM, Martinez OM (2007) Rapamycin inhibits proliferation of Epstein-Barr virus-positive B-cell lymphomas through modulation of cell-cycle protein expression. Transplantation 83:1114\u20131121","journal-title":"Transplantation"},{"key":"1976_CR46","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1242\/jcs.039131","volume":"121","author":"EA Klein","year":"2008","unstructured":"Klein EA, Assoian RK (2008) Transcriptional regulation of the cyclin D1 gene at a glance. J Cell Sci 121:3853\u20133857","journal-title":"J Cell Sci"},{"key":"1976_CR47","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/cdd.2013.86","volume":"20","author":"OV Leontieva","year":"2013","unstructured":"Leontieva OV, Demidenko ZN, Blagosklonny MV (2013) MEK drives cyclin D1 hyperelevation during geroconversion. Cell Death Differ 20:1241\u20131249","journal-title":"Cell Death Differ"},{"key":"1976_CR48","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.intimp.2006.08.009","volume":"7","author":"DO Moon","year":"2007","unstructured":"Moon DO, Park C, Heo MS, Park YM, Choi YH, Kim GY (2007) PD98059 triggers G1 arrest and apoptosis in human leukemic U937 cells through downregulation of Akt signal pathway. Int Immunopharmacol 7:36\u201345","journal-title":"Int Immunopharmacol"},{"key":"1976_CR49","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/0076-6879(91)01042-Z","volume":"201","author":"DG Hardie","year":"1991","unstructured":"Hardie DG, Haystead TA, Sim AT (1991) Use of okadaic acid to inhibit protein phosphatases in intact cells. Methods Enzymol 201:469\u2013476","journal-title":"Methods Enzymol"},{"key":"1976_CR50","doi-asserted-by":"publisher","first-page":"36079","DOI":"10.1074\/jbc.C100406200","volume":"276","author":"E Erbay","year":"2001","unstructured":"Erbay E, Chen J (2001) The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism. J Biol Chem 276:36079\u201336082","journal-title":"J Biol Chem"},{"key":"1976_CR51","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/14397595.2013.843748","volume":"24","author":"T Kaneko","year":"2014","unstructured":"Kaneko T, Amano H, Kawano S, Minowa K, Ando S, Watanabe T et al (2014) Increased serum concentration of BAFF\/APRIL and IgA2 subclass in patients with mixed connective tissue disease complicated by interstitial lung disease. Mod Rheumatol 24:310\u2013315","journal-title":"Mod Rheumatol"},{"key":"1976_CR52","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2174\/187152010793498663","volume":"10","author":"H Zhou","year":"2010","unstructured":"Zhou H, Luo Y, Huang S (2010) Updates of mTOR inhibitors. Anticancer Agents Med Chem 10:571\u2013581","journal-title":"Anticancer Agents Med Chem"},{"key":"1976_CR53","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2567.2006.02377.x","volume":"118","author":"S Haiat","year":"2006","unstructured":"Haiat S, Billard C, Quiney C, Ajchenbaum-Cymbalista F, Kolb JP (2006) Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia. Immunology 118:281\u2013292","journal-title":"Immunology"},{"key":"1976_CR54","doi-asserted-by":"publisher","first-page":"17789","DOI":"10.1073\/pnas.0406111101","volume":"101","author":"X Huang","year":"2004","unstructured":"Huang X, Di Liberto M, Cunningham AF, Kang L, Cheng S, Ely S et al (2004) Homeostatic cell-cycle control by BLyS: induction of cell-cycle entry but not G1\/S transition in opposition to p18INK4c and p27Kip1. Proc Natl Acad Sci USA 101:17789\u201317794","journal-title":"Proc Natl Acad Sci USA"},{"key":"1976_CR55","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1038\/sj.onc.1208471","volume":"24","author":"OM Tirado","year":"2005","unstructured":"Tirado OM, Mateo-Lozano S, Notario V (2005) Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax : Bcl-xL ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity. Oncogene 24:3348\u20133357","journal-title":"Oncogene"},{"key":"1976_CR56","doi-asserted-by":"publisher","first-page":"6589","DOI":"10.1158\/0008-5472.CAN-05-3018","volume":"66","author":"F Vega","year":"2006","unstructured":"Vega F, Medeiros LJ, Leventaki V, Atwell C, Cho-Vega JH, Tian L et al (2006) Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Cancer Res 66:6589\u20136597","journal-title":"Cancer Res"},{"key":"1976_CR57","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.2353\/ajpath.2006.051078","volume":"169","author":"E Peponi","year":"2006","unstructured":"Peponi E, Drakos E, Reyes G, Leventaki V, Rassidakis GZ, Medeiros LJ (2006) Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma. Am J Pathol 169:2171\u20132180","journal-title":"Am J Pathol"},{"key":"1976_CR58","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/carcin\/bgs029","volume":"33","author":"X Han","year":"2012","unstructured":"Han X, Xu B, Beevers CS, Odaka Y, Chen L, Liu L et al (2012) Curcumin inhibits protein phosphatases 2A and 5, leading to activation of mitogen-activated protein kinases and death in tumor cells. Carcinogenesis 33:868\u2013875","journal-title":"Carcinogenesis"},{"key":"1976_CR59","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.4049\/jimmunol.181.6.4080","volume":"181","author":"JE Bakema","year":"2008","unstructured":"Bakema JE, Bakker A, de Haij S, Honing H, Bracke M, Koenderman L et al (2008) Inside-out regulation of Fc alpha RI (CD89) depends on PP2A. J Immunol 181:4080\u20134088","journal-title":"J Immunol"},{"key":"1976_CR60","doi-asserted-by":"publisher","first-page":"12443","DOI":"10.1073\/pnas.1103915108","volume":"108","author":"JC Crispin","year":"2011","unstructured":"Crispin JC, Apostolidis SA, Finnell MI, Tsokos GC (2011) Induction of PP2A Bbeta, a regulator of IL-2 deprivation-induced T-cell apoptosis, is deficient in systemic lupus erythematosus. Proc Natl Acad Sci USA 108:12443\u201312448","journal-title":"Proc Natl Acad Sci USA"},{"key":"1976_CR61","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.phrs.2012.04.005","volume":"66","author":"R Roskoski Jr","year":"2012","unstructured":"Roskoski R Jr (2012) ERK1\/2 MAP kinases: structure, function, and regulation. Pharmacol Res 66:105\u2013143","journal-title":"Pharmacol Res"},{"key":"1976_CR62","doi-asserted-by":"publisher","first-page":"16726","DOI":"10.1074\/jbc.M112285200","volume":"277","author":"L Shu","year":"2002","unstructured":"Shu L, Zhang X, Houghton PJ (2002) Myogenic differentiation is dependent on both the kinase function and the N-terminal sequence of mammalian target of rapamycin. J Biol Chem 277:16726\u201316732","journal-title":"J Biol Chem"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-015-1976-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-015-1976-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-015-1976-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-015-1976-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T20:01:01Z","timestamp":1652644861000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-015-1976-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,29]]},"references-count":62,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1976"],"URL":"https:\/\/doi.org\/10.1007\/s00018-015-1976-1","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,29]]},"assertion":[{"value":"26 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}